Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes

Anticancer Research

Volumn 29, Issue 2, 2009, Pages 465-468

  Bir, Arvinder S ^a   Fora, Ahmad A ^a   Levea, Charles ^a   Fakih, Marwan G ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Colorectal cancer; Metastatic; Spontaneous regression

Indexed keywords

CAPECITABINE;

AGED; ARTICLE; CANCER PATIENT; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CASE REPORT; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LYMPH NODE METASTASIS; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM REGRESSION, SPONTANEOUS; RETROPERITONEAL SPACE;

EID: 61449173082     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E, Hao Y, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 58(1): 71-96, 2008.
2. Andre T, Boni C, Mounedji-Boudiaf L et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23): 2343-2351, 2004.
3. Douillard JY, Cunningham D, Roth AD et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355(9209): 1041-1047, 2000.
4. Saltz LB, Cox JV, Blanke C et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343(13): 905-914, 2000.
5. Kohne CH, van Cutsem E, Wils J et al: Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986. J Clin Oncol 23(22): 4856-4865, 2005.
6. de Gramont A, Figer A, Seymour M et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16): 2938-2947, 2000.
7. Goldberg RM, Sargent DJ, Morton RF et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22(1): 23-30, 2004.
8. Maindrault-Goebel F, Lledo G, Chibaudel B et al: OPTIMOX2, a large randomized phase II study of maintenance therapy or chemotherapy-free intervals (CFI) after FOLFOX in patients with metastatic colorectal cancer (MRC). A GERCOR study. J Clin Oncol 24(18): 3504, 2006.
9. Dy GK, Krook JE, Green EM et al: Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741. J Clin Oncol 25(23): 3469-3474, 2007.
10. Jonker DJ, O'Callaghan CJ, Karapetis CS et al: Cetuximab for the treatment of colorectal cancer. N Engl J Med 357(20): 2040-2048, 2007.
11. Van Cutsem E, Peeters M, Siena S et al: Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J Clin Oncol 25(13): 1658-1664, 2007.
12. Feinberg SM, Jagelman DG, Sarre RG et al: Spontaneous resolution of rectal polyps in patients with familial polyposis following abdominal colectomy and ileorectal anastomosis. Dis Colon Rectum 31(3): 169-175, 1988.
13. Shepherd A: Familial polyposis of the colon with special reference to regression of rectal polyposis after subtotal colectomy. Br J Surg 58(2): 85-91, 1971.
14. Pickens DR Jr and Farringer JL Jr: Familial polyposis and the spontaneous regression of polyps. Am Surg 35(5): 361-365, 1969.
15. Nakajima T, Suzuki M, Ando S et al: Spontaneous regression of bone metastasis from renal cell carcinoma; a case report. BMC Cancer 6: 11, 2006.
16. Inoue T, Misago N and Narisawa Y: Metastatic myxoid melanoma with partial regression of the primary lesion. J Cutan Pathol 34(6): 508-512, 2007.
17. Satzger I, Schenck F, Kapp A and Gutzmer R: Spontaneous regression of melanoma with distant metastases - report of a patient with brain metastases. Eur J Dermatol 16(4): 454-455, 2006.
18. Zaheer W, Friedland ML, Cooper EB et al: Spontaneous regression of small cell carcinoma of lung associated with severe neuropathy. Cancer Invest 11(3): 306-309, 1993.
19. Poh SC and Chiang SC: Temporary spontaneous regression of lung cancer. Singapore Med J 25(5): 354-358, 1984.
20. Fullerton JM and Hill RD: Spontaneous regression of cancer. Br Med J 2(5372): 1589-1590, 1963.
21. Roithinger FX, Wallner M, Baldinger C et al: Spontaneous regression of a small cell bronchial carcinoma. Pneumologie 49(9): 509-512, 1995.
22. Beechey RT, Edwards BE and Kelland CH: Adenocarcinoma of the colon: an unusual case. Med J Aust 144(4): 211-213, 1986.
23. Serpick AA: Spontaneous regression of colon carcinoma. Natl Cancer Inst Monogr 44: 21, 1976.
24. Rankin GB, Brown CH and Crile G Jr: Spontaneous regression of hepatic metastases from a carcinoma of the colon: 10-year follow-up of a patient with familial polyposis. Ann Surg 162: 156-159, 1965.
25. Miyamoto M, Saeki K, Tani S and Tani Y: Morphology on spontaneous regression of the autochthonous colon carcinoma in WF Osaka rat strain. Med J Osaka Univ 38(1-4): 19-25, 1989.
26. Saeki K, Miyamoto M and Kitamura H: Spontaneous colon cancer and its spontaneous regression in highly inbred Wistar Furth rats: genetic analysis. Med J Osaka Univ 38(1-4): 13-18, 1989.